Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXAZOSIN Cause Activated partial thromboplastin time prolonged? 33 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Activated partial thromboplastin time prolonged have been filed in association with DOXAZOSIN (Doxazosin). This represents 0.7% of all adverse event reports for DOXAZOSIN.

33
Reports of Activated partial thromboplastin time prolonged with DOXAZOSIN
0.7%
of all DOXAZOSIN reports
0
Deaths
33
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From DOXAZOSIN?

Of the 33 reports, 33 (100.0%) required hospitalization.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXAZOSIN. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does DOXAZOSIN Cause?

Asthma (413) Dyspnoea (393) Hypotension (385) Drug ineffective (367) Productive cough (350) Syncope (343) Dizziness (341) Wheezing (328) Condition aggravated (325) Thrombosis (274)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which DOXAZOSIN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

DOXAZOSIN vs DOXAZOSIN\DOXAZOSIN DOXAZOSIN vs DOXEPIN DOXAZOSIN vs DOXERCALCIFEROL DOXAZOSIN vs DOXIFLURIDINE DOXAZOSIN vs DOXORUBICIN

Related Pages

DOXAZOSIN Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged DOXAZOSIN Demographics